| ¿µ¹® | rejection | ÇÑ±Û | °ÅºÎ |
|---|---|---|---|
| ¼³¸í | ¾î¶² °³Ã¼ÀÇ Á¶Á÷À» ´Ù¸¥ °³Ã¼¿¡ À̽ÄÇßÀ» ¶§ ±×°ÍÀ» ¹èÁ¦ÇÏ´Â »ýü¹ÝÀÀ. °³Ã¼°£¿¡ À̽ļö¼úÀ» Çϸé óÀ½ 7~10ÀÏ Á¤µµ´Â Ç÷¾×°ø±Þµµ ȸº¹µÇ°í º°´Ù¸¥ ÀÌ»óÀ» ¹ß°ßÇÏÁö ¸øÇÏÁö¸¸, ±× ÈÄ¿¡ ±«»ç°¡ »ý±ä´Ù. ±× ¶§¹®¿¡ Àå±âÀÌ½Ä ÈÄ¿¡ °¢Á¾ Áõ»óÀÌ ¹ß»ýÇÏ¿© À̽ļö¼úÀÌ ½ÇÆÐ·Î µ¹¾Æ°¡±â ½±´Ù. »ç¶÷ÀÇ Ã¼³»¿¡ ÀÌÁ¾ÀÇ Á¶Á÷ÀÌ µé¾î°¡¸é ±×¿¡ ´ëÇØ Ç×ü°¡ ¸¸µé¾îÁø´Ù. ÀÌ´Â Ç÷¾× ¼ÓÀÇ ¸²ÇÁ±¸°¡ ±× ÀÌÁ¾Á¶Á÷¿¡ Á¢ÃËÇÏ¿© Ȱ¼ºÈµÈ »óÅ¿¡¼ ¸²ÇÁÀý·Î µÇµ¹¾Æ¿Í¼ °Å±â¼ Ç×ü¸¦ ¸¸µå´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. ÀÌ Ç×ü´Â ¼¼Æ÷¼ºÇ×ü¿Í ü¾×¼ºÇ×ü·Î ³ª´©¾îÁö¸ç ÀÌ ¾çÀÚÀÇ °øµ¿ÀÛ¿ë¿¡ ÀÇÇØ °ÅºÎ¹ÝÀÀÀÌ »ý±â´Â °ÍÀ¸·Î º¸ÀδÙ. ÀÌ´Â °³Ã¼¹æÀ§¹ÝÀÀÀ̶ó°íµµ ÇÒ ¼ö ÀÖÁö¸¸ À̽ÄÁ¶Á÷ÀÇ Ç÷°üÀº ±×°ÍµéÀÇ ÀÛ¿ëÀ¸·Î ³»ÇǼ¼Æ÷°¡ »óÇÏ¿© Ç÷ÀüÀ» Çü¼ºÇϹǷΠÇ÷ÇàÀÌ µÎÀýµÈ´Ù. ±× ¶§¹®¿¡ ±«»ç°¡ »ý±â°í ±«»çÁ¶Á÷Àº ü¿Ü·Î ¹èÃâµÈ´Ù. °ÅºÎ¹ÝÀÀÀº À̽ÄÁ÷ÈÄ¿¡ »ý±â´Â °Í, ¼öÁÖ¿¡¼ ¼ö°³¿ù ÈÄ¿¡ ºñ±³Àû ±Þ¼ºÀ¸·Î »ý±â´Â °Í, ¼ö³â ÈÄ¿¡ ¼¼È÷ »ý±â´Â °ÍÀÌ ÀÖ´Ù. Àå±â À̽Ľÿ¡´Â ÀÌ ¹ÝÀÀÀ» ¾ïÁ¦Çϱâ À§ÇØ ¸é¿ª¾ïÁ¦Á¦³ª ºÎ½Å°ÑÁúÈ£¸£¸óÀ» Åõ¿©ÇÑ´Ù. |
||
| ¿µ¹® | heart failure | ÇÑ±Û | ½ÉÀå±â´É»ó½Ç |
|---|---|---|---|
| ¼³¸í | ¸öÀÇ Á¶Á÷À̳ª ±â°ü¿¡¼ ´ë»ç¿¡ ÇÊ¿äÇÑ ¸¸Å ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾øÀ» Á¤µµ·Î ½ÉÀå±â´ÉÀÌ ÀúÇϵǾî ÀÖ´Â »óÅÂÀÌ´Ù. ½ÉÀå±â´É»ó½ÇÀº ½É±ÙÀÌ ¼öÃàÇÒ ´É·ÂÀÌ ÀúÇϵǾúÀ» ¶§³ª ½ÉÀå¿¡ ½É¹ÚÃâÀ» Çϱâ À§ÇÑ ¾Ð·ÂÀÌ Á¤»óº¸´Ù Áõ°¡µÇ¾î Á¤»óÀÇ ½ÉÀåÀÇ ¼öÃàÀ¸·Î´Â ÃæºÐÇÑ ¾çÀÇ Ç÷¾×À» °ø±ÞÇÒ ¼ö ¾ø´Â °æ¿ì, ±×¸®°í ½ÉÀå±ÙÀ°, ½ÉÀå¿¡ °É¸®´Â ¾Ð·ÂÀº Á¤»óÀ̳ª ½ÉÀå¹Úµ¿ÀÇ ÀÌ»ó¿¡ ÀÇÇØ¼ Á¤»óÀûÀÎ ¼öÃàÀÌ ºÒ°¡´ÉÇÒ °æ¿ì¿¡ »ý±ä´Ù. |
||
| ¿µ¹® | congestive heart failure | ÇÑ±Û | ¿ïÇ÷¼º½ÉÀå±â´É»ó½Ç |
|---|---|---|---|
| ¼³¸í | ½ÉÀåÀÇ ¿ø·¡ ±â´É, Áï Ç÷¾×À» ¸»ÃÊ·Î º¸³»´Â ÆßÇÁ¿Í °°Àº ±â´ÉÀÌ °ÅÀÇ ¾ø¾îÁø »óŸ¦ ¸»ÇÑ´Ù. ÇǸ¦ º¸³»´Â ÆßÇÁÀÇ ¿ªÇÒÀÌ ¸ØÃß¾úÀ¸¹Ç·Î ½ÉÀåÀ¸·Î µé¾î¿À´Â ÇÇ´Â ½ÉÀåÀ¸·Î µé¾î¿ÀÁö ¸øÇϰí Á¤¸Æ¼Ó¿¡¼ Á¤Ã¼ÇÏ°Ô µÈ´Ù. ±×¸®ÇÏ¿© Ç÷¾×ÀÇ ´ëºÎºÐÀÌ ¸»ÃÊÀÇ Á¤¸Æ¿¡ ¸Ó¹°°Ô µÇ¾î ¿©·¯ °¡Áö Áõ»óÀÌ ³ªÅ¸³´Ù. ƯÈ÷ ÇãÆÄ¸¦ µ¹¾Æ Á½ɹæÀ¸·Î µé¾î°¡¾ßÇÏ´Â Çǰ¡ ÆßÇÁ ±â´ÉÀÌ ¾ø¾îÁ®¼ ¿Þ½É¹æ¿¡ ¸¹Àº Çǰ¡ Á¤Ã¼Çϰí ÀÖ¾î¼ µé¾î°¡Áö ¸øÇؼ ÇãÆÄ¿¡ °íÀÌ°Ô µÈ´Ù. ±×·¯¸é ÇãÆÄ¿¡ »ê¼Ò¿Í ÀÌ»êÈź¼Ò¸¦ ±³È¯ÇÏ´Â ±â´ÉÀÌ ¾ø¾îÁ®¼ ¼ûÀ» ½¬Áö ¸øÇÏ´Â °á°ú¸¦ ³½´Ù. Áï ¼ûÀÌ Â÷°í ¼û½¬±â Èûµç Áõ¼¼°¡ ³ªÅ¸³´Ù. ¶Ç ¿Â¸öÀ» ¼øÈ¯ÇÑ ´ÙÀ½¿¡ ¿ì½É¹æÀ¸·Î µé¾î¿Í¾ßÇÏ´Â Çǵµ ¿ì½É¹æÀ¸·Î µé¾î¿ÀÁö ¸øÇؼ ¸»ÃÊ¿¡ Á¤Ã¼ÇϹǷΠ¿Â¸öÀÌ º×°Ô µÈ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| POF | pattern of failure; position of function; premature ovarian failure; primary ovarian failure; pyruva... |
|---|---|
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
| HCG, hCG | Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó 1. Placental Glycoprotein Hormone &nbs... |
| ASAIO | American Society for Artificial Internal Organs |
| Ht | dose equivalent to individual tissues |
| GALT | gut associated lymphoreticular tissues |
|---|---|
| CVO | Circumventricular organs |
| OAR's | organs at risk |
| AR | Acute Rejection |
| ACR | Acute cellular rejection |
| gingival tissues | The gum. (12 Dec 1998) |
|---|---|
| investing tissues | The tissue's covering or enclosing a structure. (05 Mar 2000) |
| tissues | Aggregations of similarly specialised cells united in the performance of a particular function. (12 Dec 1998) |
| accelerated rejection | A transplant rejection manifested in less than three days. (05 Mar 2000) |
| acute cellular rejection | Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage. See: primary rejection. Synonym: acute rejection. (05 Mar 2000) |
| acute kidney transplant rejection | <radiology> Findings on ultrasound: globular enlargment of the kidney, swelling and hypoechogenicity of the medullary pyramids, indistinct cortico-medullary junction, foci in the renal cortex (12 Dec 1998) |
| acute rejection | Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage. See: primary rejection. Synonym: acute rejection. (05 Mar 2000) |
| allograft rejection | The rejection of tissue transplanted between two genetically different individuals of the same species. Rejection is caused by T lymphocytes responding to the foreign major histocompatibility complex of the graft. Synonym: homograft. (05 Mar 2000) |
| parental rejection | Withholding of affection from or denial of attention to one's child. Child's withholding of affection from its parent. (05 Mar 2000) |
| rejection | 1. <immunology, surgery> Usually used of grafts. Any process leading to the destruction or detachment of a graft or other specified structure. 2. <psychology> Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection. (12 Dec 1998) |
| graft rejection | <haematology, immunology> When donated bone marrow infused during a bone marrow transplant is rejected by the patients body or does not take. (16 Dec 1997) |
| chronic allograft rejection | Immunologically mediated damage to the allograft, typically a kidney allograft, manifested by diffuse interstitial fibrosis glomerular changes, typically membranous and sclerotic in nature, as well as intimal fibrosis of the blood vessels with tubular atrophy and loss of tubular structures. (05 Mar 2000) |
| chronic rejection | A transplant rejection occurring after a few or many months, mainly from persisting serum antibody action. (05 Mar 2000) |
| primary rejection | A rejection occurring more than seven days after transplantation, mainly from a cellular immune response. (05 Mar 2000) |
| second set rejection | An accelerated rejection of a transplant that occurs when an individual has been previously sensitised to the graft. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|